Concepedia

C. Scott

CS

Statistics

Publications

3

Citations

1.9K

H-Index

3

Active since

2011

Affiliations

Princess Margaret Cancer Centre(Current)

C. Scott is an author at Princess Margaret Cancer Centre specializing in oncology, medicine, and chemotherapy.

Publications per year

2011–2020

3

Publications

3

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Phase II randomized placebo-controlled study of olaparib (AZD2281) in patients with platinum-sensitive relapsed serous ovarian cancer (PSR SOC).

Jonathan A. Ledermann, Philipp Harter, C. Gourley et al. · Journal of Clinical Oncology · 2011 · 58 citations

Medicine, Oncology, Pharmacology +14

NT-40 * Interim Analysis of the EF-14 Trial: A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM

Roger Stupp, ET Wong, C. Scott et al. · Neuro-Oncology · 2014 · 56 citations · Full text

Medicine, Oncology, Radiation Oncology +17

1–3 of 3